Skip to content
    ROP
    Earnings call· Dec 2025(Q4 FY25)

    ROPER TECHNOLOGIES INC ROP

    Jan 27, 2026 Source

    Executive summary

    Roper Technologies Q4 FY25 — Solid Execution and Strong Capital Deployment

    Roper Technologies delivered solid financial results in Q4 FY25, driven by strong margin performance and strategic capital deployment. While organic growth was below expectations, the company is investing in long-term growth initiatives, including AI product development, and maintains a conservative outlook for key segments in 2026. Management remains focused on disciplined capital allocation, balancing M&A opportunities with opportunistic share repurchases.

    Highlights

    5
    • Full-year 2025 revenue grew 12% and EBITDA grew 11%.

    • Enterprise software bookings grew in the low double-digit range for the full year 2025.

    • Q4 2025 core EBITDA margin expanded 60 basis points, representing 54% incremental margin.

    • Deployed $3.3 billion towards high-quality vertical software acquisitions in 2025, including CentralReach and Subsplash.

    • Executed opportunistic share repurchases of 1.1 million shares for $500 million in Q4 2025.

    Concerns

    5
    • Full-year 2025 organic growth was below expectations at nearly 5.5%.

    • Q4 2025 organic revenue growth was 4%, below mid-single-digit expectations, primarily due to nonrecurring revenue decline.

    • Deltek's performance was impacted by prolonged government shutdown and lower perpetual license revenue.

    • Network Software margins were lower at 52.8% due to recent bolt-ons scaling into profitability.

    • Procare did not perform to expectations in 2025 due to implementation timing issues.

    Guidance & targets

    8
    CategoryTargetConfidence
    Full-year 2026 Revenue Growth
    8% area
    high materiality
    Medium
    Full-year 2026 Organic Revenue Growth
    5% to 6%
    high materiality
    Medium
    Full-year 2026 Adjusted DEPS
    $21.30 to $21.55
    high materiality
    Medium
    Full-year 2026 Effective Tax Rate
    21% area
    medium materiality
    High
    Q1 2026 Adjusted DEPS
    $4.95 to $5.00
    high materiality
    Medium
    Application Software Organic Growth
    higher end of mid-singles range
    medium materiality
    Medium
    Network Software Organic Growth
    higher end of mid-singles range
    medium materiality
    Medium
    TEP Segment Organic Growth
    mid-single-digit range
    medium materiality
    Medium

    Segment performance

    3
    SegmentRevenueYoYQoQMargin
    Application Software
    Q4 organic growth was 4%, with recurring revenue up 6% but nonrecurring down 8%, impacting the mid-single-digit outlook. Deltek's performance was affected by the government shutdown and perpetual license revenue. Aderant saw mid-teens revenue growth and strong bookings. Vertafore had a solid year with strong recurring revenue. Procare underperformed due to implementation timing.
    Organic growth: 4% (Q4)Recurring revenue growth: 6% (Q4)Nonrecurring revenue decline: 8% (Q4)EBITDA margins: 42.5% (FY25)Core margins improved: 80 bps (FY25)Organic recurring and reoccurring revenue growth: 7% (FY25)
    $2.06B (Q4)10% (Q4)42.2% (Q4 EBITDA margin)
    Network Software
    Q4 organic growth was 5%, with recurring revenue up 6%. Margins were lower due to recent bolt-ons for DAT scaling into profitability. Nonrecurring revenue was down 3% due to lower services and customers moving from perpetual to SaaS. DAT continues to execute well despite a freight recession. Foundry is making steady progress with ARR growth.
    Organic growth: 5% (Q4)Recurring growth: 6% (Q4)Nonrecurring revenue decline: 3% (Q4)EBITDA margins: 54.1% (FY25)
    14% (Q4)52.8% (Q4 EBITDA margin)
    Technology Enabled Products (TEP)
    Q4 organic growth was 5%, with margins holding flat. NDI outperformed due to strong demand in cardiac ablation. Neptune was down slightly as expected, working through surcharge negotiations. Verathon performed well with strong growth in GlideScope and BFlex. The balance of businesses (CIVCO, FMI, Inovonics, IPA, rf IDEAS) were strong contributors.
    Organic growth: 5% (Q4)EBITDA margins: 35.7% (FY25)
    6% (Q4)34.8% (Q4 EBITDA margin)

    Operational metrics

    9
    Adjusted DEPS
    $5.21up $0.40 YoY
    Q4 FY25

    Above guidance range of $5.11 to $5.16.

    Core EBITDA Margin Expansion
    60
    Q4 FY25

    Represents 54% incremental margin.

    Shares Repurchased
    1.1M
    Q4 FY25

    Part of the $3 billion authorization, leaving $2.5 billion remaining.

    Net Leverage Ratio
    2.9x
    end of FY25

    Entering 2026 in a strong financial position.

    Available Liquidity
    $300M
    end of FY25

    Includes cash and available revolver capacity.

    Capital Deployment Capacity
    $6B
    FY26

    Capacity for potential M&A and share repurchases in 2026.

    Long-term Incremental EBITDA Margin
    45%
    Long-term

    Management's stated long-term target for incremental EBITDA margins.

    Stock Price Below Buyback Price
    15%below average Q4 buyback price
    Current

    Current stock price is approximately 15% below the average price of shares repurchased in Q4, making buybacks more attractive.

    Full-year Organic Revenue Growth
    5.4%
    FY25

    Finished around 5.4%, with deals being a tailwind. This figure was explicitly mentioned in Q&A as the ending point for FY25 organic growth.

    Industry KPIs

    3
    MetricValueDetails
    Revenue growth12%%
    Bookings billingslow double-digit range%
    Operating FCF margin rule of 4031%%

    Deals & partnerships

    3
    CentralReachVertical software acquisition

    Acquired in 2025. Building a broader growth engine through cross-sell and new product releases, including AI-enabled offerings.

    SubsplashVertical software acquisition

    Acquired in 2025. Encouraged by the durability of the revenue model and opportunity to expand value to customers.

    DATStrategic bolt-ons

    Made 3 strategic bolt-ons for DAT in 2025 that significantly automate workflow in the spot freight market.

    Risks & headwinds

    6
    Lower-than-expected organic revenue growthFY25 and Q4 FY25

    Nearly 5.5% for FY25, below expectations; 4% for Q4 FY25, below mid-single-digit outlook

    Mitigation: Upscaled talent, sharpened strategy, improved execution across the portfolio; not assuming organic growth inflection in 2026 guidance.

    Deltek's GovCon market weaknessFY25, continuing into FY26

    Meaningfully impacted by prolonged government shutdown and lower perpetual license revenue; Deltek up at lower end of mid-single digits for FY25.

    Mitigation: 2026 guidance assumes no improvement in Deltek's GovCon business; monitoring customer activity; OBBB appropriations seen as a positive development for the market over time.

    Network Software margin pressureQ4 FY25, continuing into FY26

    Q4 EBITDA margins lower at 52.8%

    Mitigation: Due to recent bolt-ons for DAT that are currently scaling into profitability; expected to accrete over time.

    Procare implementation timing issuesFY25

    Did not perform to expectations in 2025; delayed customer time to value and weighed on payments volumes.

    Mitigation: Improved payments execution, upgraded leadership team, winning competitively; top priorities are improving implementation speed and customer delight; applying learnings to other acquisitions.

    Freight market persistence for DATFY25, continuing into FY26

    Freight recession persisted throughout 2025.

    Mitigation: 2026 guidance assumes no meaningful improvement in the freight market; DAT evolving into automated marketplace, advancing AI-first operating model.

    Neptune backlog normalizationFY25, continuing into H1 FY26

    Grew modestly in FY25 notwithstanding year-long backlog normalization; Q1 FY26 expected to be in low singles area.

    Mitigation: Taking a cautious approach in 2026 guidance, underwriting modest top line weakness versus 2025; monitoring underlying demand.

    What to watch in Q1 FY26

    5

    Deltek GovCon business improvement

    Throughout FY26
    CurrentNo improvement assumed in FY26 guidance
    TargetSustained improvement in commercial activity

    Why it matters

    Deltek's performance was a primary driver of organic growth miss in FY25; improvement would provide upside to conservative FY26 guidance.

    We're going to execute and will reflect any improvement in organic growth in our guidance as it materializes throughout the year.

    Q&A highlights

    6

    What is baked into the 2026 guide for Deltek, and how is Roper protecting against future government shutdowns?

    Roper is not assuming an improvement in Deltek's performance for 2026, despite a potential comp benefit from depressed perpetual license revenue in Q4 2025. The guidance remains conservative until market improvement is observed.

    I will say we had 2 large contractor -- government contractor deals that slipped. So it was like right at the end. And so we think they'll both land in the first half of next year, but we've also sort of hedged that just in case.

    asked by Brent Thill · answered by Jason Conley

    2 min read6 chapters

    Detailed Narrative

    01

    AI Strategy and Accelerator Team

    Roper is excited about the AI product opportunity, leveraging deep domain knowledge, proprietary data, and trusted distribution within mission-critical workflows. The decentralized model allows each business to deploy AI with appropriate domain specificity. The company hired Shane Luke and Eddie Raffaele to lead the Roper AI accelerator team, coaching businesses, building a strike team, and leveraging best practices across the portfolio to increase deployment speed and precision.

    02

    Capital Allocation and M&A Pipeline

    In 2025, Roper deployed $3.3 billion into high-quality vertical software acquisitions and repurchased 1.1 million shares for $500 million in Q4. The company enters 2026 with over $6 billion in capacity for M&A and share repurchases. Management is encouraged by the size and quality of its acquisition pipeline, expecting to remain active while maintaining discipline on price and business quality, and will use buybacks opportunistically.

    03

    Deltek Performance and Outlook

    Deltek was a weaker performer in 2025 due to a challenging GovCon market, prolonged government shutdown, and impact on perpetual license revenue. While the passage of the OBBB (Omnibus Appropriations Bill) is viewed as a positive development, Roper's 2026 guidance does not include any benefit from it, maintaining a conservative posture until sustained improvement in commercial activity is observed. Commercial activity and pipeline build have been encouraging despite slower contract signatures.

    04

    DAT's Evolution and AI Integration

    Despite a persistent freight recession in 2025, DAT is evolving from a traditional load board to an automated marketplace, expanding its TAM and monetization opportunities. DAT is advancing an AI-first operating model with use cases in carrier onboarding, fraud detection, and freight matching automation. The focus is on building both sides of the network, starting with native integrations with broker TMS systems and building a high-trust carrier network.

    05

    Procare and Integration Learnings

    Procare did not meet expectations in 2025, primarily due to delays in software and payments implementation, which impacted customer time to value and payments volumes. The company has improved payments execution, upgraded leadership, and continues to win competitively. Learnings from Procare's challenges are being applied to the governance of other acquired businesses like Subsplash and CentralReach, leading to immediate corrective actions for small variances.

    06

    Neptune's Normalization and Caution

    Neptune grew modestly in 2025, supported by demand for static ultrasonic meters and cloud-based software, despite a year-long backlog normalization. Commercial challenges related to a tariff surcharging program eased late in the year, but management remains cautious and is not underwriting a recovery in its 2026 guidance. The first half of 2026 is expected to see lower growth due to continued backlog normalization.

    AI-generated summary of the company’s earnings call. Not investment advice.